相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dynamic Monitoring of EMT in CTCs as an Indicator of Cancer Metastasis
Zhen Zhang et al.
ANALYTICAL CHEMISTRY (2021)
Morphological features of breast cancer circulating tumor cells in blood after physical and biological type of isolation
Tanja Jesenko et al.
RADIOLOGY AND ONCOLOGY (2021)
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer
Pushpinder Kaur et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization
Evan N. Cohen et al.
PLOS ONE (2020)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications
Kristofor Yap et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
Michael F. Press et al.
JAMA ONCOLOGY (2019)
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells
Eva Obermayr et al.
ONCOTARGET (2018)
RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer
Julie E. Lang et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The Parsortix™ Cell Separation System-A versatile liquid biopsy platform
M. Craig Miller et al.
CYTOMETRY PART A (2018)
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun et al.
CLINICAL CANCER RESEARCH (2018)
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM(high) and EpCAM(low/negative) CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer
Rita Lampignano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer
N. V. Sankpal et al.
ONCOGENE (2017)
Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
Yvonne Maertens et al.
ONCOTARGET (2017)
The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
Lei Xu et al.
CLINICAL CANCER RESEARCH (2017)
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
S. Ingthorsson et al.
ONCOGENE (2016)
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer
Jakub Chudziak et al.
ANALYST (2016)
Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice
Michael F. Press et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
Tobias M. Gorges et al.
CLINICAL CHEMISTRY (2016)
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells
G. E. Hvichia et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
Michael F. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
Mizue Terai et al.
EBIOMEDICINE (2015)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
Francois-Clement Bidard et al.
LANCET ONCOLOGY (2014)
HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchyrnal transition and metastasis of breast cancer
Parul Gupta et al.
MOLECULAR ONCOLOGY (2014)
Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
Klaus Pantel et al.
CANCER RESEARCH (2013)
Detecting Circulating Tumor Cells: Current Challenges and New Trends
Bin Hong et al.
THERANOSTICS (2013)
Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
Antonio Giordano et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Alteration of Topoisomerase II-Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
Michael F. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Marianna Alunni-Fabbroni et al.
METHODS (2010)
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
Julie E. Lang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Minetta C. Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies
Brett G. Hollier et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
Circulating Tumor Cells in Metastatic Breast Cancer From Prognostic Stratification to Modification of the Staging System?
Shaheenah Dawood et al.
CANCER (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Is there a role for circulating tumor cells in the management of breast cancer?
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2008)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor
H Khoury et al.
ONCOGENE (2001)
分享论文
